i'm a rench capitalist, so i i work with novel science to turn them into new drugs. So for me, we implyd basically the same approaches as i would do for a french capital investment. We spent 900 million pounds up front on vaccines which we didn't know whether or not they would work. And this concept of risk and recognizing we were going to lose money did work.
Kate Bingham is the former Chair of the UK Vaccine Taskforce and she's also a shrewd business mind, having been a successful venture capitalist in sectors such as biotech for the past 30 years. She recently spoke with Jessica Pulay at the Cliveden Literary Festival to discuss how business acumen played its part in managing a team of experts from sectors such as science, medicine, industry and academia, in the race to find vaccines to combat the COVID-19 pandemic.
Learn more about your ad choices. Visit podcastchoices.com/adchoices